D. Bulut Gökten and R. Mercan, “Clinical Outcomes after Switching from Originator Infliximab to the Biosimilar Ixifi in Patients with Axial Spondyloarthritis: A Single-Center Study from Türkiye”, Rheumatol Bul, vol. 34, no. 1, pp. 4–20, May 2026, doi: 10.35465/wx09tq86.